Trademark: 87116827
Word
SUNLO
Status
Dead
Status Code
606
Status Date
Monday, January 27, 2020
Serial Number
87116827
Mark Type
4000
Filing Date
Tuesday, July 26, 2016
Published for Opposition
Tuesday, November 1, 2016
Abandoned Date
Monday, January 27, 2020

Trademark Owner History

Classifications
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
SUN LO; SUN LOW

Trademark Events
Jan 27, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 27, 2020
Abandonment - No Use Statement Filed
Mar 21, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 20, 2019
Extension 5 Granted
Mar 15, 2019
Extension 5 Filed
Mar 20, 2019
Case Assigned To Intent To Use Paralegal
Mar 15, 2019
Teas Extension Received
Nov 6, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2018
Extension 4 Granted
Nov 2, 2018
Extension 4 Filed
Nov 2, 2018
Teas Extension Received
Jun 16, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2018
Extension 3 Granted
Jun 14, 2018
Extension 3 Filed
Jun 14, 2018
Teas Extension Received
Nov 17, 2017
Notice Of Approval Of Extension Request E-Mailed
Nov 15, 2017
Extension 2 Granted
Nov 15, 2017
Extension 2 Filed
Nov 15, 2017
Teas Extension Received
May 9, 2017
Notice Of Approval Of Extension Request E-Mailed
May 5, 2017
Extension 1 Granted
May 5, 2017
Extension 1 Filed
May 5, 2017
Teas Extension Received
Jan 17, 2017
Assigned To Examiner
Dec 27, 2016
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2016
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2016
Published For Opposition
Oct 12, 2016
Notification Of Notice Of Publication E-Mailed
Sep 27, 2016
Law Office Publication Review Completed
Sep 27, 2016
Assigned To Lie
Sep 13, 2016
Approved For Pub - Principal Register
Sep 2, 2016
Notification Of Letter Of Suspension E-Mailed
Sep 2, 2016
Letter Of Suspension E-Mailed
Sep 2, 2016
Suspension Letter Written
Sep 1, 2016
Assigned To Examiner
Jul 30, 2016
Notice Of Pseudo Mark E-Mailed
Jul 29, 2016
New Application Office Supplied Data Entered In Tram
Jul 29, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24